Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2017

Giulino-Roth L, van Besien HJ, Dalton T, Totonchy JE, Rodina A, Taldone T, et al. Inhibition of Hsp90 Suppresses PI3K/AKT/mTOR Signaling and Has Antitumor Activity in Burkitt Lymphoma. Mol Cancer Ther. 2017;16(9):1779-1790.

Carniello JV, Pareja F, Santos-Zabala ML, Edelweiss M. Diagnostic dilemmas and pitfalls in ThinPrep cytology of breast fine needle aspiration biopsy:: Report of Six Cases with Histological Correlates. Diagn Cytopathol. 2017;45(7):655-661.

Rosenbaum MW, Pozdnyakova O, Geyer JT, Dal Cin P, Hasserjian RP. Ring chromosome in myeloid neoplasms is associated with complex karyotype and disease progression. Hum Pathol. 2017;68:40-46.

Nguyen GH, Olson LC, Magro CM. Upregulation of inhibitory signaling receptor programmed death marker-1 (PD-1) in disease evolution from cutaneous lymphoid dyscrasias to mycosis fungoides and Sezary's syndrome. Ann Diagn Pathol. 2017;28:54-59.

Olsen SN, Wronski A, Castaño Z, Dake B, Malone C, De Raedt T, et al. Loss of RasGAP Tumor Suppressors Underlies the Aggressive Nature of Luminal B Breast Cancers. Cancer Discov. 2017;7(2):202-217.

Whipple KM, Godfrey KJ, Solomon JP, Lin JH, Korn BS, Kikkawa DO. Glomuvenous Malformation: A Rare Periorbital Lesion of the Thermoregulatory Apparatus. Ophthalmic Plast Reconstr Surg. 2017;33(2):e36-e37.

Wang JY, Nuovo G, Kline M, Magro CM. Reexcision Perineural Invasion and Epithelial Sheath Neuroma Possibly on a Spectrum of Postinjury Reactive Hyperplasia Mediated by IL-6. Am J Dermatopathol. 2017;39(1):49-52.

Saab J, Hoda RS, Narula N, Hoda SA, Geraghty BE, Nasar A, et al. Diagnostic yield of cytopathology in evaluating pericardial effusions: Clinicopathologic analysis of 419 specimens. Cancer Cytopathol. 2017;125(2):128-137.

Pisapia DJ, Magge R, Ramakrishna R. Improved Pathologic Diagnosis-Forecasting the Future in Glioblastoma. Front Neurol. 2017;8:707.

Cao Z, Scandura JM, Inghirami GG, Shido K, Ding B-, Rafii S. Molecular Checkpoint Decisions Made by Subverted Vascular Niche Transform Indolent Tumor Cells into Chemoresistant Cancer Stem Cells. Cancer Cell. 2017;31(1):110-126.